← К результатам

Genome Med · 2016

Genome editing: progress and challenges for medical applications.

Genome medicine, 8(1): 120 PMID 27846896 DOI 10.1186/s13073-016-0378-9

Открыть в PubMed ↗ Открыть по DOI ↗

Аннотация

The development of the CRISPR-Cas platform for genome editing has greatly simplified the process of making targeted genetic modifications. Applications of genome editing are expected to have a substantial impact on human therapies through the development of better animal models, new target discovery, and direct therapeutic intervention.

Цитирование